Studies
- 
Status: ArchivedRisk factors for default in a large MDR TB treatment programme in Uzbekistan amongst patients commencing treatment from 2003 until 2008Archived by: 'System'
- 
Status: Study was withdrawn or postponedTreatment outcomes in Multi Drug Resistance TB patients in UzbekistanPrincipal investigator: Philipp du CrosLatest update: Principal investigator changed | 8th October 2016
- 
Status: ArchivedAnalysis of the Management of Isoniazid Resistant Pulmonary TB in Karakalpakstan, Uzbekistan 2003-2010Archived by: Holly Baker | 26th July 2022
- 
Status: ArchivedWhat determines Tuberculous Meningitis(TBM) treatment outcomes in a resource limited settings: retrospective review from MSF programmes in 9 countriesArchived by: Holly Baker | 26th July 2022
- 
Status: Study was withdrawn or postponedRisk factors associated with adverse TB outcomes: a multi-centric retrospective cohort studyStudy details: Observational studyPrincipal investigator: Philipp du CrosLatest update: Principal investigator changed | 9th October 2016
- 
Status: Study was withdrawn or postponedDeterminants of extra-pulmonary TB presentation and outcomes: a multi-country retrospective cohort studyStudy details: Observational studyPrincipal investigator: Philipp du CrosLatest update: Principal investigator changed | 9th October 2016
- 
Status: ArchivedEffectiveness of a simplified short regimen for Multidrug Resistant Tuberculosis treatment in Karakalpakstan, UzbekistanArchived by: 'System'
- 
Status: ArchivedChallenges and solutions to implementing drug-resistant tuberculosis programmes for children in Central AsiaArchived by: Holly Baker | 26th July 2022
- 
Status: ArchivedComparison of initiation of drug sensitive and drug resistant TB treatment in hospital versus ambulatory setting: outcomes and factors affecting outcomesArchived by: 'System'
- 
Status: ArchivedOptimising the use of control interventions for cholera and malaria in humanitarian emergenciesArchived by: Holly Baker | 4th August 2022
- 
Status: ArchivedMulti-centric analysis of drug-resistant tuberculosis patients treated with Delamanid (Dlm) in MSF projects site: a short communicationArchived by: Holly Baker | 10th August 2022
- 
Status: ArchivedTreatment Outcomes of Multi-drug resistant TB (MDR-TB) treatment: shorter MDR TB treatment regimen compared with standard of care in UzbekistanArchived by: Animesh Sinha | 25th June 2025
- 
Status: ArchivedAssociation between bedaquiline use and QT interval: a cohort analysis of data from a drug-resistant tuberculosis programme in Chechnya and UzbekistanArchived by: 'System'
